Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
ABUS Key Statistics
Stock Snapshot
Arbutus Biopharma(ABUS) stock is priced at $4.21, giving the company a market capitalization of 833.04M. It carries a P/E multiple of 5.37.
On 2026-10-23, Arbutus Biopharma(ABUS) stock traded between a low of $4.12 and a high of $4.23. Shares are currently priced at $4.21, which is +2.2% above the low and -0.5% below the high.
Arbutus Biopharma(ABUS) shares are trading with a volume of 2.03M, against a daily average of 2.78M.
In the last year, Arbutus Biopharma(ABUS) shares hit a 52-week high of $5.45 and a 52-week low of $3.50.
In the last year, Arbutus Biopharma(ABUS) shares hit a 52-week high of $5.45 and a 52-week low of $3.50.
ABUS News
The U.S. Food and Drug Administration (FDA) on Thursday lifted the clinical hold on Arbutus Biopharma Corporation’s (NASDAQ:ABUS) Investigational New Drug (IND)...
...
The latest announcement is out from Arbutus Biopharma ( (ABUS) ). On October 22, 2026, Arbutus Biopharma announced that the U.S. Food and Drug Administration l...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.